SCHEMBL723282

SCHEMBL723282

N#Cc1cc2ccccc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.48
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
LOXL2 Q9Y4K0 1/20 0.44
FLT3 P36888 1/20 0.44
CYP2A6 P11509 1/20 0.44
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
DAO P14920 2/20 0.42
HPGD P15428 2/20 0.42
SRD5A2 P31213 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BRD4 O60885 1/20 0.42
DDO Q99489 1/20 0.42
CLK1 P49759 1/20 0.42
DYRK1A Q13627 1/20 0.42
ITK Q08881 2/20 0.42
CYP2D6 P10635 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29763767 1.00 AOC3 (0.48) AOC3NPC1RAB9ALOXL2FLT3
Hydrogen Sulfide SCHEMBL29238602 0.98 AOC3 (0.47) AOC3NPC1RAB9ALOXL2FLT3
Hydrochloric Acid SCHEMBL30405205 0.98 AOC3 (0.50) AOC3NPC1RAB9ALOXL2FLT3
Hydrochloric Acid SCHEMBL4591535 0.98 AOC3 (0.50) AOC3NPC1RAB9ALOXL2FLT3
Hydrochloric Acid SCHEMBL7697249 0.98 AOC3 (0.50) AOC3NPC1RAB9ALOXL2FLT3
Selenium SCHEMBL29517759 0.98 FLT3 (0.47) AOC3NPC1RAB9ALOXL2FLT3
SCHEMBL9620368 0.82 AOC3 (0.52) AOC3NPC1RAB9ALOXL2FLT3
SCHEMBL29694493 0.82 AOC3 (0.52) AOC3NPC1RAB9ALOXL2FLT3
SCHEMBL56372 0.78 CHEK1 (0.48) AOC3NPC1RAB9ALOXL2FLT3
SCHEMBL2849094 0.78 AOC3 (0.48) AOC3NPC1RAB9ALOXL2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163061-A1 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. 2025-05-22 US claimed
EP-3928836-B1 N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-09-18 EP claimed
CN-117653741-A Photosensitizer and biological ferric oxide nano material mediated tumor targeting particles and application thereof 中国科学院长春应用化学研究所 2024-03-08 CN claimed
EP-3512850-B1 INHIBITORS OF THE MENIN-MLL INTERACTION VITAE PHARMACEUTICALS LLC (US) 2023-04-12 EP claimed
WO-2023274003-A1 ANTIBACTERIAL USE OF HEPTAMETHINE INDOCYANINE OR DERIVATIVES THEREOF 中国人民解放军陆军军医大学 2023-01-05 WO claimed
CN-115508329-A Method for detecting novel coronavirus N protein based on surface enhanced Raman spectroscopy 厦门大学 2022-12-23 CN claimed
CN-115160817-A Near-infrared cyanine dye and preparation method thereof 北京天罡助剂有限责任公司 2022-10-11 CN claimed
CN-115010643-A Benzenesulfonamide-modified heptamethine indole cyanine micromolecule, and preparation method and application thereof 中国人民解放军陆军军医大学 2022-09-06 CN claimed
CN-113337138-B Indole cyanine dye 天津全和诚科技有限责任公司 2022-08-09 CN claimed
CN-114656453-A Heptamethine indole cyanine-TEMPO chemical couple chain small molecule, preparation method and application thereof in preparing radioprotection preparation 中国人民解放军陆军军医大学 2022-06-24 CN claimed
CN-1784305-A On-press developable IR sensitive printing plates containing onium salt initiator systems KODAK POLYCHROME GRAPHICS LLC (US) 2006-06-07 CN claimed
WO-2006050937-A1 THERMALLY REACTIVE INFRARED ABSORPTION POLYMERS AND THEIR USE IN A HEAT SENSITIVE LITHOGRAPHIC PRINTING PLATE IPAGSA INDUSTRIAL, S.L. (ES) 2006-05-18 WO claimed
EP-1655317-A1 Thermally reactive infrared absorption polymers and their use in a heat sensitive lithographic printing plate Ipagsa Industrial, SL. (ES) 2006-05-10 EP claimed
WO-2005105213-A2 INDOLE AND AZAINDOLE DERIVATIVES WITH ANTITUMOR ACTION NIKEM RESEARCH S.R.L. (IT) 2005-11-10 WO claimed
CN-1200931-C Preparation method of R- (+) -6-formamido-3-N-methylamino-1, 2,3, 4-tetrahydrocarbazole FINARIS CO LTD (GB) 2005-05-11 CN claimed
US-20050019939-A1 Combination marker for liquids and method identification thereof SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT 2005-01-27 US claimed
US-6569571-B2 Cyclic property NEC TOKIN CORPORATION (JP) 2003-05-27 US claimed
US-20020132168-A1 Electrode, secondary battery and method of producing the same Envision Aesc Energy Devices Ltd. (JP) 2002-09-19 US claimed
EP-1107343-A2 Electrode, secondary battery and method of producing the same NEC CORPORATION (JP) 2001-06-13 EP claimed
US-4925901-A STORAGE STAABILITY, ONIUM ION CATALYST THE DOW CHEMICAL COMPANY (US) 1990-05-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163061-A1 INHIBITORS OF MENIN-MLL INTERACTION MLLT1, MEN1, BMI1 AOC3 4713/4885NPC1 2373/4885RAB9A 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.